Copyright
©The Author(s) 2022.
World J Gastroenterol. May 28, 2022; 28(20): 2227-2242
Published online May 28, 2022. doi: 10.3748/wjg.v28.i20.2227
Published online May 28, 2022. doi: 10.3748/wjg.v28.i20.2227
All cases | Male | Female | |
Patient characteristics | |||
n | 284 | 149 | 135 |
Age (mean ± SD) | 44.0 ± 13.3 | 44.0 ± 13.3 | 44.0 ± 13.3 |
BMI | 26.5 | 27.1 | 25.5 |
Indications | |||
OGiV | 61 (21.5%) | 30 (20.1%) | 31 (22.9%) |
Celiac disease | 80 (28.2%) | 40 (26.8%) | 40 (29.7%) |
Crohn’s or susp. Crohn’s | 47 (16.5%) | 31 (20.9%) | 16 (11.9%) |
Unexplained abdominal pain | 92 (32.4%) | 47 (31.5%) | 45 (33.3%) |
Susp. SB tumor | 4 (1.4%) | 1 (0.7%) | 3 (2.2%) |
13C urea breath test | |||
No. of performed tests | 110(38.7%) | 56 (50.1%) | 54 (49.1%) |
Positive | 36 (32.7%) | 16 (44.4%) | 20 (55.6%) |
Negative | 74 (67.3%) | 40 (54%) | 34 (46%) |
- Citation: Szalai M, Helle K, Lovász BD, Finta Á, Rosztóczy A, Oczella L, Madácsy L. First prospective European study for the feasibility and safety of magnetically controlled capsule endoscopy in gastric mucosal abnormalities. World J Gastroenterol 2022; 28(20): 2227-2242
- URL: https://www.wjgnet.com/1007-9327/full/v28/i20/2227.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i20.2227